Focus: Maxwell Biomedical is a pre-revenue biotech company developing Spatial Resynchronization Therapy delivered via an external device (MAX-SRS) to treat atrial fibrillation by maintaining sinus rhythm. Based in San Diego, the company operates as a focused cardiovascular device innovator.
Profile data last refreshed 10h ago · AI intelligence enriched 1w ago
Maxwell Biomedical is a high-risk, high-reward early-stage opportunity best suited for career-stage professionals seeking startup experience over stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Maxwell Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Maxwell Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo